| Literature DB >> 28399823 |
Cláudio Moss da Silva1, Raúl Andrés Mendoza-Sassi2, Luisa Dias da Mota2, Maíba Mikhael Nader2, Ana Maria Barral de Martinez2.
Abstract
BACKGROUND: Alcohol abuse is an important public health problem, frequently unrecognized among people living with HIV/AIDS (PLWHA), and requires investigation and intervention. It is usually associated with lower adherence to highly active antiretroviral therapy (HAART). It can also produce adverse clinical outcomes, such as changes in certain HIV markers, particularly CD4 cell counts and HIV viral loads (VLs). Thus, this study aimed to evaluate the prevalence of alcohol abuse among PLWHA, its associated risk factors and effects on CD4 cell counts and HIV VLs in southern Brazil.Entities:
Keywords: Alcohol induced disorders; Brazil; HIV/Aids; Immunologic markers; Prevalence; Risk factors
Mesh:
Substances:
Year: 2017 PMID: 28399823 PMCID: PMC5387222 DOI: 10.1186/s12879-017-2374-0
Source DB: PubMed Journal: BMC Infect Dis ISSN: 1471-2334 Impact factor: 3.090
Characteristics of the evaluated patients (n = 343)
| Characteristics | n/ | (%)/SD | |
|---|---|---|---|
| Male gender | 174 | (50.7) | |
| Age (years) | |||
| 18–34 | 99 | (28.9) | |
| 35–54 | 113 | (32.9) | |
| 55–75 | 131 | (38.2) | |
| Skin color | |||
| White | 238 | (69.4) | |
| Mixed | 55 | (16.0) | |
| Black | 50 | (14.6) | |
| Education (years) | |||
| < 8 | 185 | (53.9) | |
| ≥ 8 | 158 | (46.1) | |
| Monthly family income per capita (quartiles) (US$) | |||
| 1st | 111.0 | ± | 31.9 |
| 2nd | 201.5 | ± | 31.5 |
| 3rd | 325.0 | ± | 27.6 |
| 4th | 712.4 | ± | 384.2 |
| Homosexual/bisexual males | 47 | (13.7) | |
| Married/Cohabiting | 171 | (49.9) | |
| Sexual partners in the last year (n) | |||
| 0 | 62 | (18.1) | |
| 1 | 188 | (54.8) | |
| 2 | 38 | (11.1) | |
| ≥ 3 | 55 | (16.0) | |
| STD previous year | 42 | (12.2) | |
| AUDIT Zones | |||
| I | 245 | (71.4) | |
| II | 71 | (20.7) | |
| III | 10 | (2.9) | |
| IV | 17 | (5.0) | |
| Use of intravenous drugs | 46 | (13.4) | |
| Use of inhaled illicit drugs | 111 | (32.4) | |
| Previous hepatitis | 68 | (19.8) | |
| Using HAART | 306 | (89.2) | |
| Never used HAART | 28 | (8.2) | |
| Undetectable HIV VL | 247 | (72.0) | |
| Current CD4 (cells/mm3) | |||
| ≥ 500 | 182 | (53.0) | |
| 200–499 | 134 | (39.1) | |
| < 200 | 27 | (7.9) | |
Multivariate analysis of factors associated with alcohol abuse among HIV positive patients (n = 343)
| Variable | n (%) | Crude PR (95CI) | p | Adjusted PR (95CI) | p |
|---|---|---|---|---|---|
| Genderc,f | |||||
| Female | 27 (16.0) | 1 | 0.001 | 1 | 0.001 |
| Male | 71 (40.8) | 2.55 (1.73–3.77) | 2.88 (1.96–4.24) | ||
| Agec,f | |||||
| 18–34 | 27 (27.3) | 1 | 0.5b | 1 | 0.08a |
| 35–54 | 59 (30.7) | 1.13 (0.76–1.66) | 0.81 (0.56–1.16) | ||
| 55 or older | 12 (23.1) | 0.85 (0.47–1.53) | 0.61 (0.34–1.10) | ||
| Skin colorc,f | |||||
| White | 60 (25.2) | 1 | 0.01a | 1 | 0.04a |
| Mixed | 17 (30.9) | 1.23 (0.80–1.93) | 1.10 (0.74–1.65) | ||
| Black | 21 (42.0) | 1.67 (1.12–2.47) | 1.44 (0.98–2.13) | ||
| Educationc,f | |||||
| Each year | 0.93 (0.89–0.98) | 0.005 | 0.95 (0.90–0.99) | 0.03 | |
| Income (quartiles)c,f | |||||
| 1st | 22 (23.7) | 1 | 0.006b | 1 | 0.003b |
| 2nd | 33 (40.2) | 1.70 (1.08–2.67) | 1.67 (1.08–2.60) | ||
| 3rd | 29 (34.1) | 1.44 (0.90–2.31) | 1.18 (0.75–1.88) | ||
| 4th | 14 (16.9) | 0.71 (0.39–1.30) | 0.67 (0.37–1.21) | ||
| Married/Cohabitingc | |||||
| No | 53 (30.8) | 1 | 0.3 | 1 | 0.7 |
| Yes | 45 (26.3) | 0.85 (0.61–1.20) | 0.94 (0.69–1.29) | ||
| STDd | |||||
| No | 80 (26.6) | 1 | 0.02 | 1 | 0.5 |
| Yes | 18 (42.9) | 1.61 (1.08–2.40) | 1.15 (0.79–1.68) | ||
| Number sexual partnersd | |||||
| Up to 2 | 76 (26.4) | 1 | 0.03 | 1 | 0.2 |
| 3 or more | 22 (40.0) | 1.52 (1.04–2.21) | 1.25 (0.90–1.74) | ||
| Use of intravenous drugsd,f | |||||
| No | 70 (23.6) | 1 | 0.001 | 1 | 0.03 |
| Yes | 28 (60.9) | 2.58 (1.89–3.52) | 1.45 (1.04–2.02) | ||
| Use of inhaled illicit drugsd,f | |||||
| No | 43 (18.5) | 1 | 0.001 | 1 | 0.001 |
| Yes | 55 (49.5) | 2.67 (1.92–3.71) | 1.85 (1.28–2.68) | ||
| Previous hepatitisd | |||||
| No | 71 (25.8) | 1 | 0.02 | 1 | 0.5 |
| Yes | 27 (39.7) | 1.54 (1.08–2.19) | 1.14 (0.80–1.60) | ||
| Length of HIV infectione | |||||
| Each year | 0.997 (0.965–1.031) | 0.9 | 0.989 (0.957–1.021) | 0.5 | |
| Use of HAARTe | |||||
| No | 7 (18.9) | 1 | 0.2 | 1 | 0.2 |
| Yes | 91 (29.7) | 1.57 (0.79–3.13) | 1.69 (0.81–3.54) | ||
aLinear trend test; bHeterogeneity test; c1st level; d2nd level; e3rd level; ffinal model
Linear regression coefficients of AUDIT score for CD4 cell counts and viral load values (n = 343)
| Crude | Adjustedb | |||||||
|---|---|---|---|---|---|---|---|---|
| Coeff.a | 95CI | P | R2 | Coeff. | 95CI | P | R2 | |
| CD4 cells | −9.18 | −13.90/−4.46 | 0.001 | 0.038 | - 5.14 | −10.23/−0.04 | 0.04 | 0.078 |
| (cells /mm3) | ||||||||
| Viral load | 0.005 | −0.01/0.02 | 0.6 | 0.002 | 0.01 | −0.005/0.03 | 0.1 | 0.33 |
| (Log10 HIV RNA) | ||||||||
aCoefficient, bAdjusted for age, gender, skin color, education, income, relationship status, STD, number of sexual partners, previous hepatitis, length of HIV infection, use of HAART and use of intravenous or inhaled drugs